Company Update (NYSE:MDT): Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

[GlobeNewswire] – First TAVR Device Indicated for Replacement of Failed Surgical Heart Valves Expands Patient Population That Can Benefit from Minimally Invasive Procedure DUBLIN – March 31, 2015 – Medtronic plc (NYSE: … . . . → Read More: Company Update (NYSE:MDT): Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures Similar Articles: Company Update (NYSE:MDT): Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare Conference Stock Update (NYSE:MDT): Medtronic wins conditional EU approval for $43 bln Covidien buy Market Update: Medtronic Inc (NYSE:MDT) – Medtronic seeks EU approval for $43 bln Covidien deal